Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:activeIngredient |
favipiravir
|
| gptkbp:approvalYear |
June 2020
|
| gptkbp:approvedBy |
gptkb:India
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
FabiFlu
|
| gptkbp:manufacturer |
gptkb:Glenmark_Pharmaceuticals
|
| gptkbp:marketedIn |
gptkb:India
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:usedFor |
gptkb:COVID-19
|
| gptkbp:bfsParent |
gptkb:Favipiravir
|
| gptkbp:bfsLayer |
7
|